Revance Therapeutics

RVNC

NASDAQHealth Care

Income Statement

Total Revenue$237.08M

Gross Profit$169.27M

Operating Income$-145.86M

EBITDA$-133.54M

EBIT$-139.46M

Pre-tax Income$-179.31M

Net Income$-166.86M

Cash Equivalent$83.25M

Total Debt$483.58M

Book Value$-138.62M

Book Value Per Share-1.38

Return on Equity (ROE)-2828.57%

Return on Assets (ROA)-67.72%

Return on Invested Capital (ROI)-90.78%

Net Profit Margin-138.43%

Current Ratio3.80

Quick Ratio3.16

Long-Term Debt / Equity30.11